Citigroup Inc Moderna, Inc. Call Options Transaction History

Citigroup Inc

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 10, 2024	SELL	$85.37 - $115.44 $1.11 Million - $1.5 Million	-13,000 Reduced 68.42%	6,000 $639,000
Q2 2023 Aug 10, 2023	SELL	$118.5 - $160.53 $20.4 Million - $27.7 Million	-172,400 Reduced 90.07%	19,000 $2.31 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $4.48 Million - $6.5 Million	33,000 Added 20.83%	191,400 $29.4 Million
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $11.5 Million - $20.5 Million	97,400 Added 159.67%	158,400 $28.5 Million
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $472,280 - $776,720	4,000 Added 7.02%	61,000 $7.21 Million
Q2 2022 Aug 10, 2022	SELL	$117.13 - $176.59 $12.2 Million - $18.5 Million	-104,500 Reduced 64.71%	57,000 $8.14 Million
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $1.96 Million - $3.64 Million	-15,500 Reduced 8.76%	161,500 $27.8 Million
Q4 2021 Feb 10, 2022	BUY	$225.82 - $368.51 $22.2 Million - $36.2 Million	98,200 Added 124.62%	177,000 $45 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $17.5 Million - $38.2 Million	78,800 New	78,800 $30.3 Million

949

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.